The dose-response characteristics of inhaled corticosteroids when used to treat asthma: An overview of Cochrane systematic reviews

Respiratory Medicine

Volumn 100, Issue 8, 2006, Pages 1297-1306

  Adams, N P ^a   Jones, P W ^b  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b ST GEORGE S HOSPITAL   (United Kingdom)

Author keywords

Asthma; Disease management; Inhaled corticosteroids; Review; Systematic

Indexed keywords

BECLOMETASONE DIPROPIONATE; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BUDESONIDE; CORTICOSTEROID; FLUTICASONE PROPIONATE; PREDNISOLONE;

ASTHMA; CLINICAL TRIAL; COCHRANE LIBRARY; DISEASE SEVERITY; DOSE RESPONSE; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG MEGADOSE; DRUG WITHDRAWAL; DYSPHONIA; HOARSENESS; HUMAN; LOW DRUG DOSE; META ANALYSIS; MOUTH DISEASE; PHARYNGITIS; PRIORITY JOURNAL; REVIEW; SORE THROAT; STATISTICAL SIGNIFICANCE; SYSTEMATIC REVIEW; THRUSH; TREATMENT OUTCOME;

ADMINISTRATION, INHALATION; ADULT; ANDROSTADIENES; ANTI-ASTHMATIC AGENTS; ASTHMA; BECLOMETHASONE; BRONCHODILATOR AGENTS; BUDESONIDE; CHILD; DOSE-RESPONSE RELATIONSHIP, DRUG; EVIDENCE-BASED MEDICINE; FORCED EXPIRATORY VOLUME; HUMANS; PEAK EXPIRATORY FLOW RATE; TREATMENT OUTCOME;

EID: 33745383646     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rmed.2006.04.015     Document Type: Review

References (38)

1. Suissa S., and Ernst P. Inhaled corticosteroids: impact on asthma morbidity and mortality. J Allergy Clin Immunol 107 (2001) 937-944
2. British Thoracic Society, Scottish Intercollegiate Guidelines Network. British guideline on the management of asthma. Thorax 58 suppl 1 (2003) 1-24
3. National Institute of Health. Global strategy for asthma management and prevention (2002), National Institute of Health, Bethseda, MD [NIH Publication No. 02-3659]
4. Adams NP, Bestall JC, Malouf R, Lasserson TJ, Jones PW. Beclomethasone versus placebo for chronic asthma. In: The Cochrane Library, Issue 1. Chichester, UK: Wiley; 2005.
5. Adams N.P., Bestall J.C., and Jones P.W. Budesonide versus placebo for chronic asthma in children and adults. The Cochrane Library, Issue 4 (1999), Wiley, Chichester, UK
6. Adams N.P., Bestall J.C., Lasserson T.J., and Jones P.W. Fluticasone versus placebo for chronic asthma in adults and children. The Cochrane Library, Issue 3 (2005), Wiley, Chichester, UK
7. Adams N.P., Bestall J.C., and Jones P.W. Beclomethasone at different doses for long-term asthma. The Cochrane Library, Issue 4 (1999), Wiley, Chichester, UK
8. Adams N.P., Bestall J.C., and Jones P.W. Budesonide at different doses for chronic asthma. The Cochrane Library, Issue 4 (2001), Wiley, Chichester, UK
9. Adams N.P., Bestall J.C., Jones P.W., Lasserson T.J., Griffiths B., and Cates C. Fluticasone at different doses for chronic asthma in adults and children. The Cochrane Library, Issue 3 (2005), Wiley, Chichester, UK
10. Powell H, Gibson PG. High dose versus low dose inhaled corticosteroid as initial starting dose for asthma in adults and children. In: The Cochrane Library, Issue 4.Chichester, UK: Wiley; 2003.
11. National Institute of Health. Global strategy for asthma management and prevention (1995), National Institute of Health, Bethesda, MD [NIH Publication No. 95-3659]
12. Drepaul B.A., Payler D.K., Qualtrough J.E., et al. Becotide or becodisks? A controlled study in general practice. Clin Trials J 26 (1989) 335-344
13. Verberne A.A., Frost C., Duiverman E.J., Grol M.H., and Kerrebijn K.F. Addition of salmeterol versus doubling the dose of beclomethasone in children with asthma. Am J Respir Crit Care Med 158 (1998) 213-219
14. Chervinsky P., van As A., Bronsky E.A., et al. Fluticasone propionate aerosol for the treatment of adults with mild to moderate asthma. The Fluticasone Propionate Asthma Study Group. J Allergy Clin Immunol 94 (1994) 676-683
15. Nathan R.A., Li J.T., Finn A., et al. A dose-ranging study of fluticasone propionate administered once daily via multidose powder inhaler to patients with moderate asthma. Chest 118 (2000) 296-302
16. O'Sullivan S., Cormican L., Murphy M., Poulter L.W., and Burke C.M. Effects of varying doses of fluticasone propionate on the physiology and bronchial wall immunopathology in mild-to-moderate asthma. Chest 122 (2002) 1966-1972
17. Pearlman D.S., Stricker W., Weinstein S., et al. Inhaled salmeterol and fluticasone: a study comparing monotherapy and combination therapy in asthma. Ann Allergy Asthma Immunol 82 (1999) 257-265
18. Dahl R., Lundback B., Malo J.L., et al. A dose-ranging study of fluticasone propionate in adult patients with moderate asthma. International Study Group. Chest 104 (1993) 1352-1358
19. Galant S.P., Lawrence M., Meltzer E.O., Tomasko M., Baker K.A., and Kellerman D.J. Fluticasone propionate compared with theophylline for mild-to-moderate asthma. Ann Allergy Asthma Immunol 77 (1996) 112-118
20. Katz Y., Lebas F.X., Medley H.V., and Robson R. Fluticasone propionate 50 micrograms BID versus 100 micrograms BID in the treatment of children with persistent asthma. Fluticasone Propionate Study Group. Clin Ther 20 (1998) 424-437
21. Lawrence M., Wolfe J., Webb D.R., et al. Efficacy of inhaled fluticasone propionate in asthma results from topical and not from systemic activity. Am J Respir Crit Care Med 156 (1997) 744-751
22. Noonan M.J., Chervinsky P., Wolfe J., Liddle R., Kellerman D.J., and Crescenzi K.L. Dose-related response to inhaled fluticasone propionate in patients with methacholine-induced bronchial hyperresponsiveness: a double-blind, placebo-controlled study. J Asthma 35 (1998) 153-164
23. Pearlman D.S., Noonan M.J., Tashkin D.P., et al. Comparative efficacy and safety of twice daily fluticasone propionate powder versus placebo in the treatment of moderate asthma. Ann Allergy Asthma Immunol 78 (1997) 356-362
24. Pearlman D.S., Kerwin E., Kim K., et al. Fluticasone prorionate HFA-134 A significantly improves asthma control in inhaled corticosteroid dependent asthmatics. AM J Respir Crit Care Med 165 suppl 8 (2002) A770
25. Peden D.B., Berger W.E., Noonan M.J., et al. Inhaled fluticasone propionate delivered by means of two different multidose powder inhalers is effective and safe in a large pediatric population with persistent asthma. J Allergy Clin Immunol 102 (1998) 32-38
26. Sheffer A.L., LaForce C., Chervinsky P., Pearlman D., and Schaberg A. Fluticasone propionate aerosol: efficacy in patients with mild to moderate asthma. Fluticasone Propionate Asthma Study Group. J Fam Pract 42 (1996) 369-375
27. Wasserman S.I., Gross G.N., Schoenwetter W.F., et al. A 12-week dose-ranging study of fluticasone propionate powder in the treatment of asthma. J Asthma 33 (1996) 265-274
28. Wolfe J.D., Selner J.C., Mendelson L.M., Hampel Jr. F., and Schaberg A. Effectiveness of fluticasone propionate in patients with moderate asthma: a dose-ranging study. Clin Ther 18 (1996) 635-646
29. Raphael G.D., Lanier R.Q., Baker J., Edwards L., Rickard K., and Lincourt W.R. A comparison of multiple doses of fluticasone propionate and beclomethasone dipropionate in subjects with persistent asthma. J Allergy Clin Immunol 103 (1999) 796-803
30. Verona E., Petrov D., Cserhati E., et al. Fluticasone propionate in asthma: a long term dose comparison study. Arch Dis Childhood 88 (2003) 503-509
31. Kraan J., Koeter G.H., van der Mark T.W., et al. Dosage and time effects of inhaled budesonide on bronchial hyperreactivity. Am Rev Respir Dis 137 (1988) 44-48
32. Pauwels R.A., Lofdahl C.G., Postma D.S., et al. Effect of inhaled formoterol and budesonide on exacerbations of asthma. Formoterol and Corticosteroids Establishing Therapy (FACET) International Study Group. N Engl J Med 337 (1997) 1405-1411
33. Ayres J.G., Bateman E.D., Lundback B., and Harris T.A.J. High dose fluticasone propionate, 1 mg daily, versus fluticasone propionate, 2 mg daily, or budesonide, 1.6 mg daily, in patients with chronic severe asthma. Eur Respir J 8 (1995) 579-586
34. Busse W.W., Chervinsky P., Condemi J., et al. Budesonide delivered by Turbuhaler is effective in a dose-dependent fashion when used in the treatment of adult patients with chronic asthma. J Allergy Clin Immunol 101 (1998) 457-463
35. Shapiro G., Bronsky E.A., LaForce C.F., et al. Dose-related efficacy of budesonide administered via a dry powder inhaler in the treatment of children with moderate to severe persistent asthma. J Pediatr 132 (1998) 976-982
36. Nelson H.S., Bernstein I.L., Fink J., et al. Oral glucocorticosteroid-sparing effect of budesonide administered by Turbuhaler: a double-blind, placebo-controlled study in adults with moderate-to-severe chronic asthma. Pulmicort Turbuhaler Study Group. Chest 113 (1998) 1264-1271
37. Noonan M., Chervinsky P., Busse W.W., et al. Fluticasone propionate reduces oral prednisone use while it improves asthma control and quality of life. Am J Respir Crit Care Med 152 (1995) 1467-1473
38. Nelson H.S., Busse W.W., deBoisblanc B.P., et al. Fluticasone propionate powder: oral corticosteroid-sparing effect and improved lung function and quality of life in patients with severe chronic asthma. J Allergy Clin Immunol 103 (1999) 267-275